• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Blogs » The Carlat Psychiatry Podcast » Kraepelin on Clancy Part 3

The Carlat Psychiatry Podcast
The Carlat Psychiatry Podcast RSS FeedRSS

Clear, engaging, and practical updates on clinical psychiatry.
Earn CME for listening to the podcast with a Podcast CME Subscription.
Listen for free here or using Apple Podcasts and Spotify.
General Psychiatry

Kraepelin on Clancy Part 3

November 16, 2026
Chris Aiken, MD and Kellie Aiken, PMHNP
PDF

Chris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

shutterstock_1644878488.jpg


As Lindsay Clancy’s hallucinations grow louder, we look at how postpartum psychosis presents, why the DSM struggles to classify it, and the treatment that brought 98% of women with this disorder to full recovery. Plus: The first trial of lumateperone in acute mania.

Publication Date: 11/16/2026

Duration: 30 minutes, 28 seconds

Transcript:

KELLIE AIKEN: As Lindsay Clancy’s hallucinations grow louder, we look at how postpartum psychosis presents, why the DSM struggles to classify it, and the treatment that brought 98% of women with this disorder to full recovery. Plus: The first trial of lumateperone in acute mania. In this episode, Lindsay Clancy takes the first dose of a medication that usually helps in bipolar disorder and postpartum psychosis, but things don’t go as planned.

CHRIS AIKEN:
 Welcome to the Carlat Psychiatry Podcast, keeping psychiatry honest since 2003. I’m Chris Aiken, the editor-in-chief of the Carlat Report.


KELLIE AIKEN: And I’m Kellie Aiken, a psychiatric NP and a dedicated reader of every issue. As we close our series on the Clancy case, we’ll look at whether psychosis can worsen on quetiapine, and how Lindsay’s symptoms compare to typical cases of postpartum psychosis and postpartum bipolar disorder. At the end, we’ll cover a new trial in bipolar mania. But first, a preview of the CME quiz; click on the show notes to earn those credits.

1. Which antipsychotic has acute efficacy in both the manic and depressive phases of bipolar disorder?
A. Cariprazine
B. Aripiprazole
C. Brexpiprazole
D. Lurasidone

CHRIS AIKEN:
 It’s November 2022, and Lindsay Clancy is five months postpartum. Her son is starting to babble, respond to familiar faces, and reach out to explore and play, but Lindsay’s mind is somewhere else. She’s dissociated, disoriented, and forgetful. The world around her seems unreal, and she feels disconnected from her own body. She blames mirtazapine. That antidepressant isn’t helping, and may be making things worse, but whatever their cause, these symptoms are likely early signs of a psychosis that would soon take control of her mind and her actions.

KELLIE AIKEN: 
In this episode, I’m going to read straight from the malpractice complaint. On November 29, Lindsay began treatment with her third clinician, a nurse practitioner. Lindsay reported that she was "anxious and frightened about what is happening" and that she blamed herself. The nurse practitioner considered bipolar disorder and prescribed quetiapine. After starting quetiapine, Lindsay's condition took a dramatic turn for the worse. She felt "emotionless" and "like a zombie," and attributed this affective blunting to the quetiapine. She developed suicidal ideation and began experiencing what she described to the NP as "intrusive thoughts" but which were actually auditory hallucinations. The voice said, "I will not be the same. I want to die."

CHRIS AIKEN: Some psychiatrists argued that this couldn’t be postpartum psychosis because it started too late, five months after delivery. But most of the numeric cut-offs we learn in psychiatry are surrounded by a wide bell curve. Postpartum psychosis typically begins around 10 days after delivery. Recently, the largest phenomenologic study of postpartum psychosis confirmed that 10 days was the mean onset, but it also found a wide spread, with some cases starting six months after delivery.

KELLIE AIKEN: But whether she had postpartum psychosis or bipolar with psychosis is less clear, and may just be mincing words. Postpartum psychosis isn’t even recognized in DSM; instead it’s a specifier that we attach to mood disorder - either a bipolar or unipolar. Actually, it’s two specifiers: postpartum onset and psychotic features. But it wasn’t always this way. DSM-II recognized it as “psychosis of childbirth.” In 1980, DSM-III removed that category as part of a broader push to remove any suggestion of causality from psychiatric disorders.

CHRIS AIKEN:
 This summer, a group of perinatal psychiatry experts argued for reinstating postpartum psychosis in the next DSM edition, and placing it in the bipolar section. Their timing coincided with the trial, but it was long in the planning. Here’s their logic: The genetic risks for postpartum psychosis overlap with bipolar disorder, as does its course. Half of women with postpartum psychosis go on to develop bipolar disorder. The other half recover fully, and almost none develop schizophrenia. That’s from the latest research, and Kraepelin reported similar figures in his 1913 textbook. He had 38 women with postpartum mania and psychosis; 65% went on to have manic-depression, and the other 35% recovered fully without further episodes. He saw childbirth as an extreme risk factor, one that could bring on bipolar at a later age than the typical teenage origins. When it did start that way, in older women postpartum, he thought it was less likely to return.

KELLIE AIKEN: 
The paper proposed new criteria, including “confusional” symptoms like those Lindsay had. This month, the APA agreed to create a section on peripartum disorders with postpartum psychosis in its own place. The proposed criteria require at least one of the following within three months of childbirth: 
  • A mania or mixed state
  • Delusions
  • Hallucinations
  • Disorganized speech or formal thought disorder
  • Disorganized, confusional, or catatonic behavior
  • Or depression with psychotic features
CHRIS AIKEN: Though the experts wanted it in the bipolar section, the APA wasn’t ready for that. That’s unfortunate, as placing it in the bipolar category would clarify treatment. Guidelines recommend lithium, antipsychotics, and as-needed benzodiazepines for sleep and agitation. With that approach, 98% of women reached full recovery. Without it, 1 in 25 go on to murder their children. They also recommend starting lithium right after delivery in women with a past episode of postpartum psychosis. Aim for 0.8 to 1.0 mmol/L during the first month. Begin tapering after 3 months but continue for a full year. 

KELLIE AIKEN: 
In 2022, Lindsay Clancy visited over half a dozen psychiatrists and NPs. Her signs and symptoms pointed toward bipolar disorder: postpartum onset, worsening on antidepressants, mixed features; but only one of them, an NP, seems to have recognized the bipolar.

NP AUDIO CLIP:
  “Did you express to, uh, Ms. Clancy thoughts that you had about her diagnosis?”  “I did.” “And what was that?” “I discussed with her and her husband the possibility of potentially an underlying bipolar disorder. I based this on several factors, one of them being that she had such what we call an activating response to the Zoloft. It's unusual for somebody to describe taking Zoloft and then going forty-eight hours without sleep and not being tired. S- so that raised my clinical suspicion a bit”.

CHRIS AIKEN: 
Quetiapine was a reasonable choice, with the potential to address all of her symptoms with one pill: Depression, anxiety, insomnia, and bipolar. Many patients would have recovered on quetiapine, but Lindsay felt worse. Antipsychotics are complicated drugs, and they can cause paradoxical reactions. Although they treat mania, most antipsychotics have case reports of causing mania, and quetiapine has the most: 22 in all. One reason may be that the body converts quetiapine into norquetiapine, a metabolite with SNRI-like properties. This is a particular risk for people who are ultrarapid metabolizer at CYP3A4, the enzyme that officiates this conversion, or taking a medication that speeds up the enzyme like carbamazepine. But this is a rare risk, very rare. Quetiapine has a number needed to treat of 4, so, just a 1 in 4 chance of working beyond the placebo. The most likely explanation is that quetiapine didn’t do anything but add some side effects and the illness got worse on its own. Quetiapine’s quirks aside, the first step when you see paradoxical medication reactions and sudden mental status changes like this is to reassess the diagnosis and look for medical causes. If she had neurologic signs, we’d look for autoimmune encephalitis, which happens in around 4% of women with postpartum psychosis. We’d check for it with anti-NMDA antibodies. Iron deficiency and autoimmune thyroid disease are also common postpartum. Around 1 in 5 women with postpartum psychosis have this thyroid problem. We’d check ferritin, thyroid panel, and anti-thyroid peroxidase antibodies. Other labs to screen for in postpartum psychosis are CBC, metabolic panel, calcium, B12, folate, thiamine, and a urine drug screen.

KELLIE AIKEN: 
On December 2, 2022, Lindsay reported to the NP that she had lost fifteen pounds, had no appetite, was experiencing panic attacks and confusion, and had a lack of attention over the past four days. Two days later, she was so frightened by the hallucinations that she called the New Bedford Suicide Hotline seeking help. She was told there was no emergency because she said she had no specific plan as to how she would kill herself. The next day, she went to the emergency room again and again was turned away, for the same reasons.

CHRIS AIKEN:
I’m seeing two patterns here that raise my suspicion for bipolar. One is persistence – there’s an urgency to her distress. She goes to the emergency room, gets turned away, and comes back the next day. Most patients with depression give up, but depression with mixed manic features has a desperate edge we call dysphoria. Last spring, a patient called our office a dozen times in as many minutes until he got the receptionist, then asked for an urgent, same-day appointment for depression. He was in a mixed state. The other sign is that this is more than depression. There’s anxiety, panic, confusion, hallucinations. None of those are in the DSM criteria for bipolar, but Emil Kraepelin placed them front-and-center of his descriptions of mania and mixed states: Panic attacks, anxious excitement, clouding of consciousness; they are confused, bewildered, and completely lose orientation for time and place. Illusions and hallucinations. Their face appears black in the mirror. They see an open grave and hear the devil's laugh, the weeping of their dead mother, the screaming of children, the song of angels. All possible sins are brought before the patient as if he were a criminal; the voices entice them to suicide: “Do something to yourself,” “Hang yourself,” “You are a dog of a person, a swine, you must die like a beast.” All of these are soft signs of bipolar. They don’t make the diagnosis, but they raise our index of suspicion.

KELLIE AIKEN: 
On December 15, Lindsay was uninterested in anything, exhausted, and could not get out of bed. The hallucinations were loud and continued all day, saying, "I will never be the same," "I will never be me again," and "You are damaged. You will never be the same. The only option is to die." Lindsay told her husband Patrick, I have thoughts of harming the kids." She also told her mother about these thoughts. Because she was in a psychotic state, Lindsay also had paranoid delusions that people could hear her thoughts and that she would be locked in a hospital and have her children taken away. On December 21, 2022, Lindsay admitted herself to the partial hospitalization day program at Women & Infants Hospital in Providence, Rhode Island, Lindsay's chief complaint at Women & Infants was "I feel numb and crazy depressed." She reported feeling "crazy depressed, numb to all emotion, can't feel love," that her "life is becoming a disaster," that she couldn't "feel fear," and that she was "messed up beyond repair." She had lost fifteen pounds in a month, had no motivation, and reported that "It takes all the effort in the world just to breathe." The hospital physicians decided she did not have bipolar disorder because she had no history of mania or hypomania and no family history of bipolar disorder. They believed that many of her symptoms were medication-induced and recommended lowering the quetiapine. Following the quetiapine reduction, Lindsay’s suicidal ideation resurged. By December 29, 2022, Lindsay told her husband, "I can't tough it out anymore. I need to go to McLean Hospital." On December 31, 2022, she was admitted to McLean Hospital—the nation's top-ranked psychiatric hospital—due to her severe depression and suicidal ideation. Lindsay's admitting symptoms included passive suicidal ideation, feeling detached, hopelessness, depression, no appetite or energy to perform activities of daily living, no motivation, anhedonia, racing thoughts, inability to organize her thoughts, memory problems, anxiety, and insomnia. Her insight and judgment were documented as "limited.” She was admitted to a locked unit on New Year's Eve, and there was a "skeleton crew" because of the holiday. Patients spent their evening doing puzzles and coloring. Nurses stayed behind a desk and glass. Lindsay did not see a doctor until January 3, 2023—three days after admission. That doctor stopped quetiapine and benzodiazepines and prescribed trazodone for sleep. The next day, Lindsay asked if she could go home for her daughter’s fifth birthday. Because her thoughts had improved since the quetiapine decrease, she was approved for discharge.

CHRIS AIKEN: Hospitals often use trazodone for sleep, perhaps because patients are unlikely to misuse it, but this antidepressant comes with other risks. When a hospitalized patient has depression, there’s a 50% chance that it’s a bipolar type, and trazodone can trigger mania and rapid cycling like other antidepressants. Even without bipolar disorder, some people get worse on trazodone. Its metabolite, mCPP, can cause dysphoria, hallucinations, and suicidality when its levels climb too high. It’s a rare reaction, but one that has shown up in clinical trials, and it’s more common if the CYP2D6 enzyme is slowed down, as is often is for people taking SSRIs.

KELLIE AIKEN: 
One day after her discharge from McLean, Lindsay returned to her original psychiatrist, who diagnosed her with "chronic" "major depressive disorder, single episode, moderate." The doctor switched her benzodiazepine to diazepam in order to taper it, with a plan to add an antidepressant in the future. Two weeks later, she was still experiencing debilitating depression. She had to force herself to do anything. The hallucinations continued: "You should harm the children." "You should kill yourself." "You will never be the same. The only option is to die." She felt like a "zombie." The psychiatrist prescribed Amitriptyline—a tricyclic that was recommended by the McLean team—at 10 mg per day. On January 20, 2023, because Lindsay was having such awful thoughts and was so numb and emotionless, she researched "What is a psychopath?" to see if she was one, and whether there was a cure. On January 23, 2023, her depression continued unchanged, and her amitriptyline was increased to 20 mg. That night, Lindsay did not sleep.

CHRIS AIKEN: Tricyclics like amitriptyline are the antidepressants most likely to worsen bipolar disorder. With their cardiotoxicity, they’re also the last antidepressant you’d want to give a suicidal patient. I don’t use tricyclics unless I’ve carefully ruled out bipolar disorder and suicidality, and maybe they did that. Maybe they used a structured interview, or a screening test, and it’s just not mentioned in this one-sided malpractice claim. Either way, this goes on often enough in practice that we’re calling it out. Even when bipolar is diagnosed, antidepressants are still among the most common drugs prescribed. And if you read the FDA’s labeling carefully, like a prosecuting attorney is going to do, you’ll see it right there: They recommend screening for bipolar disorder with a tool like the Mood Disorder Questionnaire before starting any antidepressant.

KELLIE AIKEN: 
On January 24, 2023, Lindsay woke severely depressed with suicidal thoughts. She gave the children breakfast. She took Cora to the pediatrician because Cora complained of a stomachache. Later, she went to the backyard with the children, built a snowman, and sent a picture to Patrick and her mother. The suicidal hallucinations continued all day nonstop. Later in the afternoon, the voice began saying, "You should harm the children.” Lindsay thought about dinner and realized she had not prepared anything. She asked Patrick about takeout. She looked at a map to see how long it would take because she did not want to be alone and needed help. As soon as Patrick left to pick up the food, there was a loud, demanding, repetitious voice: "This is your last chance. Kill the children so you can kill yourself." "THIS IS YOUR LAST CHANCE. YOU HAVE TO KILL THE KIDS SO YOU CAN KILL YOURSELF." Lindsay felt a force come over her. She experienced command auditory hallucinations: a "demanding, powerful male voice explicitly ordered her. She felt an overwhelming, irresistible compulsion to comply, entering a dissociative "dream-like state" where her physical actions felt utterly disconnected from her conscious volition. She perceived her "body was just acting," and she was merely watching herself do it. She reported she had "no choice" but to follow these compelling directives. Lindsay described: "I lost all control. My body started acting without any control on my part. I was just following commands, 'all action.' This voice demanded action."

CHRIS AIKEN: Kraepelin wrote of depressed patients who swung suddenly into dangerous, manic-psychotic states: “At times more violent states of excitement may be interpolated. The patients scream, throw themselves on the floor… make desperate attacks on the surroundings. Serious attempts at suicide are in these states extremely frequent. God commanded a female patient to kill her relatives.” 

KELLIE AIKEN: 
Lindsay proceeded to strangle each of her children, uttering, "Go to God, baby." Following these acts, she undertook a severe suicide attempt, ingesting a substantial quantity of various medications, self-inflicting lacerations to her wrists and neck, and jumping from a second-floor window approximately twenty feet to the ground below. Lindsay suffered catastrophic injuries including a thoracic spinal cord injury resulting in permanent paralysis below the sternum. She also suffered multiple closed fractures of her cervical and thoracic vertebrae and multiple rib fractures.  Lindsay later recalled the 35-minute episode as if it was a dream. Shortly afterwards, she met with a chaplain and told him that she had heard a male voice telling her that if she didn't act, neither she nor her children would be safe.

CHRIS AIKEN: In the 1920s, Karl Jasper's laid out a three-level hierarchy of psychiatric diagnoses that we still follow today. At the top are medical causes and substance-induced disorders. In the middle are psychiatric disorders that take over the mind, drastically altering the person from their usual self – manic, psychosis, and melancholic depression. At the bottom, after we’ve ruled the other two levels out, are problems that overlap more with everyday life – depression, anxiety, binge eating, inattention, insomnia, PTSD, problems that often stem from a mismatched collision between our temperament and an outside stress. The avoidant person who gets divorced, then isolated and depressed. The impulsive person who develops an addiction. I can’t say whether Lindsay Clancy is guilty or innocent under the law. I’m not an attorney, and I’m not a forensic psychiatrist. But in Jasper’s diagnostic ladder, I think she was at least at a level II. She wasn’t a level I – this wasn’t cocaine intoxication or encephalopathy. Nor was she a level III – she wasn’t an antisocial who hid her murderous impulses until acting on them at the age of 32. And I’ve never heard of an antisocial who tried to take their own life along with their victims. No, this was a drastic change from her usual self – a level II in Jasper’s hierarchy. But can it happen that fast? You’ve heard it from Kraepelin and from perinatal experts. Mania and postpartum psychosis are states of rapid flux; even Hollywood got this right. In Mr. Jones, Richard Gere plays a man with bipolar. One minute, he’s a happy-go-lucky carpenter working on a building. The next minute, he thinks he’s a superhero and is jumping off the building, and I don’t think he did it on purpose.

KELLIE AIKEN: When people kill during altered states of mind like psychosis and intoxication, the grief is still devastating, even if it happens out of sight, unsanctioned and unacknowledged by society. Like Lindsay, many who’ve experienced this don’t remember the episode or the killing. They live with that split-off identity, ashamed, cut off from continuity with their lives and the outside world, confined in hospitals, unable to visit the gravesite, the family, the places and objects that help us access memory and process grief. Today’s research update is a phase 3 trial of lumateperone in acute mania, by Dr. Cutler and colleagues. They presented it as a poster at Psych Congress in New Orleans, so it hasn’t appeared in a journal yet.

CHRIS AIKEN:
 Lumateperone, or Caplyta, carries FDA approval for bipolar I and II depression, for schizophrenia, and as an add-on in major depression. It blocks serotonin 2A receptors, modulates dopamine D2, and mildly inhibits serotonin reuptake. That last property raised the possibility that lumateperone could cause mania, something seen in a few case reports. This trial looked at whether it could treat mania?

KELLIE AIKEN: 
They randomized 354 hospitalized adults with bipolar I mania to lumateperone 42 mg or placebo for three weeks. About a third had psychotic features, and 15% had mixed features. Ninety-two percent finished the trial.

CHRIS AIKEN:
 Lumateperone worked. Mania scores fell 4.8 points more on the antipsychotic, a moderate effect size of 0.7, and the drug separated from placebo by day 3. Side effects were mild, led by headache, dry mouth, nausea, and sedation; but fewer than 2% quit because of side effects.

KELLIE AIKEN: 
Now the caveats. This is a poster, and it hasn’t gone through peer review. Johnson & Johnson, the manufacturer, funded it, and most of the authors work for the company. It’s a three-week trial, and lumateperone has no preventative data in bipolar disorder.

CHRIS AIKEN: When I choose an antipsychotic for mania, I look for one that will also treat the depressions that dominate this illness. There are only three: Cariprazine, quetiapine, and now lumateperone. Among them, quetiapine is the only one with robust preventative data, but it comes with weight gain and sedation. Cariprazine and lumateperone are better tolerated but costlier. Cariprazine failed its maintenance trial. Lumateperone hasn’t had a maintenance trial yet, but it has stronger data than cariprazine in bipolar depression, with a larger effect size and efficacy in both bipolar I and II.

KELLIE AIKEN:
 Here's what I learned from Dr. Aiken's new Fact Book on Complementary and Alternative Medicine in Psychiatry. Some of these therapies have support from large, well-designed trials, like Saffron and Light therapy in depression, or Lavender in anxiety. For others, the evidence is weaker, but they address a broad array of problems that make them a good fit for complex comorbidities. For someone with autism, anxiety, obesity, and irritable bowel syndrome... think Probiotics.  For someone with ADHD who is irritable and has elevated triglyceride... consider Omega-3 fatty acids.



The Carlat CME Institute is accredited by the ACCME to provide continuing medical education for physicians. Carlat CME Institute maintains responsibility for this program and its content. Carlat CME Institute designates this enduring material educational activity for a maximum of one quarter (.25) AMA PRA Category 1 CreditsTM. Physicians or psychologists should claim credit commensurate only with the extent of their participation in the activity.

Related Products

Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CAM1e_3DCover_Spiral_sm.png

    Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

    Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2205347851.jpg
    General Psychiatry

    Balancing Focus and Cardiovascular Risk with ADHD Treatment

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.